# Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/telbivudine-versus-lamivudine-in-chinese-patients-with-chronic-hepatitis-b/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jinlin Hou,You‐Kuan Yin,Dao-zhen Xu,Deming Tan,Junqi Niu,Xia-qiu Zhou,Yuming Wang,Limin Zhu,Yongwen He,Hong Ren,Mobin Wan,Chengwei Chen,Shanming Wu,Yagang Chen,Jiazhang Xu,Qinhuan Wang,Lai Wei,George Chao,Barbara Fielman Constance,George Harb,Nathaniel Brown,Jidong Jia |
| Citations | 163 |
| DOI | 10.1002/hep.22075 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2018076560 |
| PMID | 18080339 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Hong Ren](https://scholariq.org/researchers/hong-ren/)

## Paper primary topic

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Paper topics

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatitis Viruses Studies and Epidemiology](https://scholariq.org/topics/hepatitis-viruses-studies-and-epidemiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.